CHRO

Channel Therapeutics Corporation CHRO

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CHRO TVRD TNFA OMGA TSBX IMVIF CRVO APGN CSCI BIOR
6M -94.23 % -62.34 % -69.68 % -88.68 % -1.31 % 0.00 % -23.87 % -38.57 % 0.00 % 0.00 %
YTD -81.33 % 34.29 % -95.48 % -81.77 % -33.95 % 0.00 % 217.49 % -40.75 % -0.37 % 0.00 %
1Y -87.38 % 34.29 % -96.83 % -95.79 % -46.69 % 0.00 % -46.28 % -93.88 % -26.49 % -95.15 %
3Y -97.19 % 34.29 % -97.28 % -97.81 % -96.77 % -100.00 % -9.23 % -96.38 % -54.67 % -99.80 %
5Y -97.19 % 34.29 % -97.28 % -99.11 % -96.77 % -100.00 % -88.89 % -96.38 % -54.67 % -99.99 %
10Y -97.19 % 34.29 % -97.28 % -99.11 % -96.77 % -100.00 % -99.99 % -96.38 % -54.67 % -99.99 %
From the beginning -97.19 % 34.29 % -97.28 % -99.11 % -96.77 % -100.00 % -100.00 % -96.38 % -54.67 % -99.99 %

Dividend